Copyright Reports & Markets. All rights reserved.

Global Heparin Sodium API Market Research Report 2021

Request for Sample of this report
Buy now

1 Heparin Sodium API Market Overview

  • 1.1 Product Overview and Scope of Heparin Sodium API
  • 1.2 Heparin Sodium API Segment by Type
    • 1.2.1 Global Heparin Sodium API Market Size Growth Rate Analysis by Type 2021 VS 2027
    • 1.2.2 Unfractionated Heparin
    • 1.2.3 Low Molecular Heparin
  • 1.3 Heparin Sodium API Segment by Application
    • 1.3.1 Global Heparin Sodium API Consumption Comparison by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Treatment of Venous Thromboembolism
    • 1.3.3 Complications of Pregnancy
    • 1.3.4 Cardioversion of Atrial Fibrillation/Flutter
    • 1.3.5 Other
  • 1.4 Global Market Growth Prospects
    • 1.4.1 Global Heparin Sodium API Revenue Estimates and Forecasts (2016-2027)
    • 1.4.2 Global Heparin Sodium API Production Capacity Estimates and Forecasts (2016-2027)
    • 1.4.3 Global Heparin Sodium API Production Estimates and Forecasts (2016-2027)
  • 1.5 Global Market Size by Region
    • 1.5.1 Global Heparin Sodium API Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027
    • 1.5.2 North America Heparin Sodium API Estimates and Forecasts (2016-2027)
    • 1.5.3 Europe Heparin Sodium API Estimates and Forecasts (2016-2027)
    • 1.5.5 China Heparin Sodium API Estimates and Forecasts (2016-2027)
    • 1.5.5 Japan Heparin Sodium API Estimates and Forecasts (2016-2027)

2 Market Competition by Manufacturers

  • 2.1 Global Heparin Sodium API Production Capacity Market Share by Manufacturers (2016-2021)
  • 2.2 Global Heparin Sodium API Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Heparin Sodium API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.4 Global Heparin Sodium API Average Price by Manufacturers (2016-2021)
  • 2.5 Manufacturers Heparin Sodium API Production Sites, Area Served, Product Types
  • 2.6 Heparin Sodium API Market Competitive Situation and Trends
    • 2.6.1 Heparin Sodium API Market Concentration Rate
    • 2.6.2 Global 5 and 10 Largest Heparin Sodium API Players Market Share by Revenue
    • 2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region

  • 3.1 Global Production Capacity of Heparin Sodium API Market Share by Region (2016-2021)
  • 3.2 Global Heparin Sodium API Revenue Market Share by Region (2016-2021)
  • 3.3 Global Heparin Sodium API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.4 North America Heparin Sodium API Production
    • 3.4.1 North America Heparin Sodium API Production Growth Rate (2016-2021)
    • 3.4.2 North America Heparin Sodium API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.5 Europe Heparin Sodium API Production
    • 3.5.1 Europe Heparin Sodium API Production Growth Rate (2016-2021)
    • 3.5.2 Europe Heparin Sodium API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.6 China Heparin Sodium API Production
    • 3.6.1 China Heparin Sodium API Production Growth Rate (2016-2021)
    • 3.6.2 China Heparin Sodium API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.7 Japan Heparin Sodium API Production
    • 3.7.1 Japan Heparin Sodium API Production Growth Rate (2016-2021)
    • 3.7.2 Japan Heparin Sodium API Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Heparin Sodium API Consumption by Region

  • 4.1 Global Heparin Sodium API Consumption by Region
    • 4.1.1 Global Heparin Sodium API Consumption by Region
    • 4.1.2 Global Heparin Sodium API Consumption Market Share by Region
  • 4.2 North America
    • 4.2.1 North America Heparin Sodium API Consumption by Country
    • 4.2.2 United States
    • 4.2.3 Canada
  • 4.3 Europe
    • 4.3.1 Europe Heparin Sodium API Consumption by Country
    • 4.3.2 Germany
    • 4.3.3 France
    • 4.3.4 U.K.
    • 4.3.5 Italy
    • 4.3.6 Russia
  • 4.4 Asia Pacific
    • 4.4.1 Asia Pacific Heparin Sodium API Consumption by Region
    • 4.4.2 China
    • 4.4.3 Japan
    • 4.4.4 South Korea
    • 4.4.5 Taiwan
    • 4.4.6 Southeast Asia
    • 4.4.7 India
    • 4.4.8 Australia
  • 4.5 Latin America
    • 4.5.1 Latin America Heparin Sodium API Consumption by Country
    • 4.5.2 Mexico
    • 4.5.3 Brazil

5 Production, Revenue, Price Trend by Type

  • 5.1 Global Heparin Sodium API Production Market Share by Type (2016-2021)
  • 5.2 Global Heparin Sodium API Revenue Market Share by Type (2016-2021)
  • 5.3 Global Heparin Sodium API Price by Type (2016-2021)

6 Consumption Analysis by Application

  • 6.1 Global Heparin Sodium API Consumption Market Share by Application (2016-2021)
  • 6.2 Global Heparin Sodium API Consumption Growth Rate by Application (2016-2021)

7 Key Companies Profiled

  • 7.1 Hepalink
    • 7.1.1 Hepalink Heparin Sodium API Corporation Information
    • 7.1.2 Hepalink Heparin Sodium API Product Portfolio
    • 7.1.3 Hepalink Heparin Sodium API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.1.4 Hepalink Main Business and Markets Served
    • 7.1.5 Hepalink Recent Developments/Updates
  • 7.2 Changshan Pharm
    • 7.2.1 Changshan Pharm Heparin Sodium API Corporation Information
    • 7.2.2 Changshan Pharm Heparin Sodium API Product Portfolio
    • 7.2.3 Changshan Pharm Heparin Sodium API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.2.4 Changshan Pharm Main Business and Markets Served
    • 7.2.5 Changshan Pharm Recent Developments/Updates
  • 7.3 Qianhong Bio-pharma
    • 7.3.1 Qianhong Bio-pharma Heparin Sodium API Corporation Information
    • 7.3.2 Qianhong Bio-pharma Heparin Sodium API Product Portfolio
    • 7.3.3 Qianhong Bio-pharma Heparin Sodium API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.3.4 Qianhong Bio-pharma Main Business and Markets Served
    • 7.3.5 Qianhong Bio-pharma Recent Developments/Updates
  • 7.4 Opocrin
    • 7.4.1 Opocrin Heparin Sodium API Corporation Information
    • 7.4.2 Opocrin Heparin Sodium API Product Portfolio
    • 7.4.3 Opocrin Heparin Sodium API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.4.4 Opocrin Main Business and Markets Served
    • 7.4.5 Opocrin Recent Developments/Updates
  • 7.5 Pfizer
    • 7.5.1 Pfizer Heparin Sodium API Corporation Information
    • 7.5.2 Pfizer Heparin Sodium API Product Portfolio
    • 7.5.3 Pfizer Heparin Sodium API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.5.4 Pfizer Main Business and Markets Served
    • 7.5.5 Pfizer Recent Developments/Updates
  • 7.6 Aspen Oss
    • 7.6.1 Aspen Oss Heparin Sodium API Corporation Information
    • 7.6.2 Aspen Oss Heparin Sodium API Product Portfolio
    • 7.6.3 Aspen Oss Heparin Sodium API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.6.4 Aspen Oss Main Business and Markets Served
    • 7.6.5 Aspen Oss Recent Developments/Updates
  • 7.7 King-friend Biochemical Pharmaceutical
    • 7.7.1 King-friend Biochemical Pharmaceutical Heparin Sodium API Corporation Information
    • 7.7.2 King-friend Biochemical Pharmaceutical Heparin Sodium API Product Portfolio
    • 7.7.3 King-friend Biochemical Pharmaceutical Heparin Sodium API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.7.4 King-friend Biochemical Pharmaceutical Main Business and Markets Served
    • 7.7.5 King-friend Biochemical Pharmaceutical Recent Developments/Updates
  • 7.8 Bioibérica
    • 7.8.1 Bioibérica Heparin Sodium API Corporation Information
    • 7.8.2 Bioibérica Heparin Sodium API Product Portfolio
    • 7.8.3 Bioibérica Heparin Sodium API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.8.4 Bioibérica Main Business and Markets Served
    • 7.7.5 Bioibérica Recent Developments/Updates
  • 7.9 Dongcheng Biochemicals
    • 7.9.1 Dongcheng Biochemicals Heparin Sodium API Corporation Information
    • 7.9.2 Dongcheng Biochemicals Heparin Sodium API Product Portfolio
    • 7.9.3 Dongcheng Biochemicals Heparin Sodium API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.9.4 Dongcheng Biochemicals Main Business and Markets Served
    • 7.9.5 Dongcheng Biochemicals Recent Developments/Updates
  • 7.10 Jiulong Biochemicals
    • 7.10.1 Jiulong Biochemicals Heparin Sodium API Corporation Information
    • 7.10.2 Jiulong Biochemicals Heparin Sodium API Product Portfolio
    • 7.10.3 Jiulong Biochemicals Heparin Sodium API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.10.4 Jiulong Biochemicals Main Business and Markets Served
    • 7.10.5 Jiulong Biochemicals Recent Developments/Updates
  • 7.11 Tiandong
    • 7.11.1 Tiandong Heparin Sodium API Corporation Information
    • 7.11.2 Tiandong Heparin Sodium API Product Portfolio
    • 7.11.3 Tiandong Heparin Sodium API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.11.4 Tiandong Main Business and Markets Served
    • 7.11.5 Tiandong Recent Developments/Updates
  • 7.12 Xinbai
    • 7.12.1 Xinbai Heparin Sodium API Corporation Information
    • 7.12.2 Xinbai Heparin Sodium API Product Portfolio
    • 7.12.3 Xinbai Heparin Sodium API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.12.4 Xinbai Main Business and Markets Served
    • 7.12.5 Xinbai Recent Developments/Updates
  • 7.13 Yino Pharma Limited
    • 7.13.1 Yino Pharma Limited Heparin Sodium API Corporation Information
    • 7.13.2 Yino Pharma Limited Heparin Sodium API Product Portfolio
    • 7.13.3 Yino Pharma Limited Heparin Sodium API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.13.4 Yino Pharma Limited Main Business and Markets Served
    • 7.13.5 Yino Pharma Limited Recent Developments/Updates
  • 7.14 Deebio
    • 7.14.1 Deebio Heparin Sodium API Corporation Information
    • 7.14.2 Deebio Heparin Sodium API Product Portfolio
    • 7.14.3 Deebio Heparin Sodium API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.14.4 Deebio Main Business and Markets Served
    • 7.14.5 Deebio Recent Developments/Updates

8 Heparin Sodium API Manufacturing Cost Analysis

  • 8.1 Heparin Sodium API Key Raw Materials Analysis
    • 8.1.1 Key Raw Materials
    • 8.1.2 Key Raw Materials Price Trend
    • 8.1.3 Key Suppliers of Raw Materials
  • 8.2 Proportion of Manufacturing Cost Structure
  • 8.3 Manufacturing Process Analysis of Heparin Sodium API
  • 8.4 Heparin Sodium API Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

  • 9.1 Marketing Channel
  • 9.2 Heparin Sodium API Distributors List
  • 9.3 Heparin Sodium API Customers

10 Market Dynamics

  • 10.1 Heparin Sodium API Industry Trends
  • 10.2 Heparin Sodium API Growth Drivers
  • 10.3 Heparin Sodium API Market Challenges
  • 10.4 Heparin Sodium API Market Restraints

11 Production and Supply Forecast

  • 11.1 Global Forecasted Production of Heparin Sodium API by Region (2022-2027)
  • 11.2 North America Heparin Sodium API Production, Revenue Forecast (2022-2027)
  • 11.3 Europe Heparin Sodium API Production, Revenue Forecast (2022-2027)
  • 11.4 China Heparin Sodium API Production, Revenue Forecast (2022-2027)
  • 11.5 Japan Heparin Sodium API Production, Revenue Forecast (2022-2027)

12 Consumption and Demand Forecast

  • 12.1 Global Forecasted Demand Analysis of Heparin Sodium API
  • 12.2 North America Forecasted Consumption of Heparin Sodium API by Country
  • 12.3 Europe Market Forecasted Consumption of Heparin Sodium API by Country
  • 12.4 Asia Pacific Market Forecasted Consumption of Heparin Sodium API by Region
  • 12.5 Latin America Forecasted Consumption of Heparin Sodium API by Country

13 Forecast by Type and by Application (2022-2027)

  • 13.1 Global Production, Revenue and Price Forecast by Type (2022-2027)
    • 13.1.1 Global Forecasted Production of Heparin Sodium API by Type (2022-2027)
    • 13.1.2 Global Forecasted Revenue of Heparin Sodium API by Type (2022-2027)
    • 13.1.3 Global Forecasted Price of Heparin Sodium API by Type (2022-2027)
  • 13.2 Global Forecasted Consumption of Heparin Sodium API by Application (2022-2027)

14 Research Finding and Conclusion

    15 Methodology and Data Source

    • 15.1 Methodology/Research Approach
      • 15.1.1 Research Programs/Design
      • 15.1.2 Market Size Estimation
      • 15.1.3 Market Breakdown and Data Triangulation
    • 15.2 Data Source
      • 15.2.1 Secondary Sources
      • 15.2.2 Primary Sources
    • 15.3 Author List

    The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027. by Application segment also provides consumption during the forecast period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Unfractionated Heparin
    Low Molecular Heparin

    Segment by Application
    Treatment of Venous Thromboembolism
    Complications of Pregnancy
    Cardioversion of Atrial Fibrillation/Flutter
    Other

    By Company
    Hepalink
    Changshan Pharm
    Qianhong Bio-pharma
    Opocrin
    Pfizer
    Aspen Oss
    King-friend Biochemical Pharmaceutical
    Bioibérica
    Dongcheng Biochemicals
    Jiulong Biochemicals
    Tiandong
    Xinbai
    Yino Pharma Limited
    Deebio

    Production by Region
    North America
    Europe
    China
    Japan

    Consumption by Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    Buy now